REACTA 2024
02-03 August @Taipei Medical University Xinyi Campus
From Ideation to Validation:
Clinical Trials in the Digital Era
About REACTA 2024
The Regional Asian Clinical Trial Association (REACTA) was launched in 2013 by Taipei Medical University and clinical research centers of excellence in Japan, Korea, and Malaysia. Aiming to combine expertise in clinical trial, REACTA creates a platform to promote knowledge exchange and international collaboration in clinical trials across Asia.
REACTA 2024, taking place on 2 – 3 August in Taipei, will showcase key achievements of clinical trials across Taiwan, Japan, Korea, Malaysia and the wider Asia region, with focuses on the introduction of new technologies and application of AI to trial implementation in the digital era.
Forum Information
Theme
Topics of sessions
From Ideation to Validation: Clinical Trials in the Digital Era
- Clinical trials in the digital age
- Future of decentralised clinical trials (DCT)
- Updates on latest regulations and management practices on clinical trials
- Experience sharing of key clinical trial studies in Taiwan and in Asia
- Research innovation & clinical validation: the journey
- International collaborative trials: opportunities and challenges
Contact Us
Organizers
2024 REACTA TW